Canopy Health Innovation, Inc (2019)
Chercheur principal: Julie Carrier, Université de Montréal.
Contrats de recherche avec l'industrie privée
Projet en cours
A double-blind, randomized, placebo-controlled multi-center dose-titration study on the efficacy and safety of CH1-921 on sleep initiation and maintenance in subjects with insomnia.
Autres projets récents
Idorsia (2019)
Multi-center, double-blind, randomized, placebo-controlled, parallel-group, polysomnography study to assess the efficacy and safety of ACT-541468 in adult and elderly subjects with insomnia disorder.
Novartis (2013)
A randomized double-blind multi-center crossover study of the sleep effects of a single dose of triprolidine 5 mg, diphenhydramine 50 mg and placebo on measures of nighttime sleep and daytime alertness in a 3 hour phase-advance model in healthy volunteers.
Merck Frosst Canada (2010)
Parts A Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel group, study to evaluate the safety and efficacy of MK-4305 in patients with primary insomnia.